SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000093751-23-000186
Filing Date
2023-02-03
Accepted
2023-02-03 15:52:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 Allogene_Therapeutics_Inc.txt SC 13G 8563
  Complete submission text file 0000093751-23-000186.txt   10358
Mailing Address ONE LINCOLN STREET BOSTON MA 02111
Business Address ONE LINCOLN STREET BOSTON MA 02111 617 786-3000
STATE STREET CORP (Filed by) CIK: 0000093751 (see all company filings)

IRS No.: 042456637 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G
SIC: 6022 State Commercial Banks

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90685 | Film No.: 23585600
SIC: 2836 Biological Products, (No Diagnostic Substances)